SCHEMBL23629089

SCHEMBL23629089

CCc1cc(Nc2ccccc2)c2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.51
▸ JAK3 P52333 2/20 0.51
▸ CCNK O75909 1/20 0.47
▸ CCNA2 P20248 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CCND3 P30281 1/20 0.47
▸ CDK9 P50750 1/20 0.47
▸ CDK6 Q00534 1/20 0.47
▸ CKS1B P61024 2/20 0.46
▸ SKP1 P63208 2/20 0.46
▸ SKP2 Q13309 2/20 0.46
▸ P2RX7 Q99572 1/20 0.46
▸ NAMPT P43490 1/20 0.46
▸ GPR119 Q8TDV5 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ NR2F2 P24468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30074968 0.79 MAPT (0.47) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL28575536 0.79 MAPT (0.47) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL23575854 0.76 MAPT (0.59) ALDH1A1MAPTLMNAHTTSMN1; SMN2
SCHEMBL23575564 0.75 CSF1R (0.54) PTPN11SLC2A1
SCHEMBL13979397 0.74 GPR119 (0.61) JAK2JAK3NAMPTGPR119ALDH1A1
SCHEMBL12070614 0.73 MAPT (0.50) NAMPTGPR119ALDH1A1MAPTLMNA
SCHEMBL17826997 0.73 CHRM2 (0.50) CKS1BSKP1SKP2ALDH1A1LMNA
SCHEMBL12788964 0.73 PDK2 (0.44) JAK2JAK3CKS1BSKP1SKP2
SCHEMBL23575656 0.72 MAPT (0.60) ALDH1A1MAPTLMNAHTTSMN1; SMN2
SCHEMBL27236227 0.72 RAD52 (0.67) CCNKCCNA2CDK2CCND3CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3846800-A1 COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1 C4 Therapeutics, Inc. (US) 2021-07-14 — — EP disclosed
Send feedback